# ElixirTrials — full content Source: https://elixirtrials.com/ French version: https://elixirtrials.com/fr/ Last updated: 2026-07-22 --- ## Who we are ElixirTrials is a decentralized clinical-trial platform that activates U.S. community hospitals as fully functional clinical-trial sites. We provide turnkey infrastructure, AI-powered operations, and access to a unified sponsor network — bringing trials to patients rather than asking patients to travel to trials. **Slogan**: Trials belong where patients live. **Founded**: 2025 **Headquarters**: United States **Contact**: info@elixirtrials.com --- ## The problem - Someone you love may need a clinical trial. Today, 88% of hospitals can't run trials. That's not a gap. It's a wall. - 80% of trials fail to meet enrollment targets. - $8M lost per day when trials are delayed. - 88% of U.S. hospitals lack infrastructure to run clinical trials. - For most patients, clinical trials are out of reach. ### Maria's story Maria drove 4 hours each way. Twice a week. For six months. Then she stopped. Not because she chose to. Because the system made it impossible. The trial lost a patient. Science lost a data point. Maria's disease didn't wait. Maria didn't fail. The trial didn't fail. The system failed. It's time to fix the broken system. --- ## What we do Clinical-trial access for all is now a reality. Trials belong where patients live. The trial comes to the patient. Not the other way around. That's the magic of ElixirTrials. ### For community hospitals — "You treat the patients." - Zero upfront cost to the site. - 100% of trial revenue retained by the site. - Turnkey infrastructure and staffing support. - AI-powered workflow. - Access to a steady pipeline of clinical trials. - New revenue stream and elevated standard of care. ### For sponsors — "You bring the science." - Unlock access to unreachable patients at scale. - Accelerated enrollment across a unified network. - Scaled access to diverse, underrepresented patients. - One contract, one network, simplified execution. - Standardized, regulatory-grade data across all sites. - Rapid study start-up with pre-enabled infrastructure. - Predictable delivery through centralized operations. --- ## The thesis Rebuilding clinical trials around patients. New sites. More patients. High-quality data. --- ## Cauldron — Clinical Trial OS The humans make the decisions. The AI does the busy work. Scheduling, documentation, compliance, reporting — all clinical-trial workflows. Handled. --- ## Founders ### Heather Grey — CEO - 15+ years building and scaling clinical-trial businesses. - Former Tempus TIME Trial builder. - Led large-scale pharma partnerships. - Global leader of clinical-trial and Real World Data teams. ### Noah Dolev — PhD, CTO - PhD, Computational Neuroscience. - 15+ years building AI products. - 6 startups. - 2 unicorns — Wix, Gong. --- ## Newsroom Press releases and announcements: https://elixirtrials.com/newsroom/ - 2026-07-20 — ElixirTrials Emerges from Stealth to Build the Infrastructure Needed to Bring Clinical Trials to Every Community — https://www.einpresswire.com/article/927873995/elixirtrials-emerges-from-stealth-to-build-the-infrastructure-needed-to-bring-clinical-trials-to-every-community --- ## FAQ **What is ElixirTrials?** ElixirTrials is a decentralized clinical-trial platform that activates community hospitals as fully functional trial sites. We provide turnkey infrastructure, AI-powered operations, and access to a unified sponsor network — bringing trials to patients rather than asking patients to travel to trials. **What is a decentralized clinical trial?** A decentralized clinical trial (DCT) is a trial design that delivers visits, data collection, or care closer to where patients live — rather than requiring travel to a central academic site. DCTs improve enrollment, retention, and patient diversity. **How does ElixirTrials work with community hospitals?** ElixirTrials makes community hospitals trial-ready at zero upfront cost. We supply technology, staffing, regulatory support, and access to a steady pipeline of sponsor trials. The hospital retains 100% of its rate-card revenue and the patient relationship. **How does ElixirTrials work with trial sponsors?** Sponsors run trials through a single unified network of pre-enabled community-hospital sites. The result: accelerated enrollment, broader access to underrepresented patients, standardized regulatory-grade data, one contract, and faster study start-up. **Who founded ElixirTrials?** ElixirTrials was founded in 2025 by Heather Grey (CEO; 15+ years scaling clinical-trial businesses, formerly built the Tempus TIME Trial) and Noah Dolev (CTO; PhD in computational neuroscience, builder at Wix and Gong). **Where does ElixirTrials operate?** ElixirTrials operates in the United States, partnering with community hospitals and trial sponsors nationally. **What is Cauldron?** Cauldron is ElixirTrials' clinical-trial operations platform — AI-assisted scheduling, documentation, compliance, and reporting that handles routine trial workflows so clinical staff can focus on patient care and decision-making. --- ## Glossary - **Decentralized clinical trial (DCT)** — trial design that delivers visits, data collection, or care closer to where patients live, rather than requiring travel to a central academic site. - **Site activation** — the multi-month process of qualifying, contracting, and operationally enabling a clinical-trial site to begin enrollment. - **Enrollment** — recruiting eligible patients into a clinical trial and obtaining informed consent. - **Sponsor** — the pharmaceutical, biotech, or research organization that designs and funds a clinical trial. - **Principal investigator (PI)** — the licensed clinician at a site who is medically and regulatorily responsible for the trial there. - **Real-world data (RWD)** — health data routinely collected outside of trials (EHRs, claims, registries) that can inform or augment trial evidence. - **Hybrid trial** — a trial that combines decentralized elements with traditional site-based elements. - **Cauldron** — ElixirTrials' clinical-trial operations platform (AI-assisted scheduling, documentation, compliance, reporting). - **Rate card** — the standardized per-procedure fees a trial site collects from a sponsor. --- ## Regulatory posture - Operates under a decentralized site-activation model designed to expand clinical-trial access to underserved and geographically distributed patient populations. - All participating hospital sites undergo formal feasibility assessment, regulatory documentation review, and protocol-specific staff training prior to site initiation. - Data collection, patient safety monitoring, and adverse-event reporting are conducted in accordance with 21 CFR Part 11 and applicable Good Clinical Practice standards. - Full audit-trail capability across all site activities via the Cauldron platform. - Operates in compliance with ICH-GCP guidelines and applicable FDA and EMA regulations. - All trial activities are conducted under institutional review board (IRB) oversight. - Site partnerships are subject to executed master service agreements. --- ## Sources The three statistics on the home page are widely cited in clinical-trial industry literature. Authoritative sources to be confirmed and linked in a future revision: - 88% of U.S. hospitals lack trial infrastructure — - 80% of trials miss enrollment targets — - $8M lost per day when trials are delayed — --- ## Contact Heather Grey, CEO — info@elixirtrials.com